E Fund Management, China’s leading mutual fund manager, highlights six sector-specific ETFs—spanning artificial intelligence, robotics & smart devices, cloud computing & big data, biotechnology, new energy and space technology—each tracking CSI indexes to capture growth in China’s technology-driven markets.

Key points

  • Top five China tech ETFs collect US$7.87 billion net inflows, led by US$1.17 billion into the AI ETF.
  • E Fund highlights six cutting-edge sectors—AI, robotics, cloud computing, biotech, energy and space—via tailored CSI-tracked ETFs.
  • Assets under management range from US$489 million in cloud computing to US$2.23 billion in the CSI Artificial Intelligence ETF.

Q&A

  • What is an ETF?
  • How do sector-specific ETFs work?
  • What is the CSI Artificial Intelligence Index?
  • What does net inflow mean?
  • What is ETF Connect?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...


Read full article

Biotechnology in Longevity Science

Biotechnology applies biological systems and organisms to develop products and technologies that improve human health and lifespan. In longevity science, biotechnology focuses on understanding and intervening in the molecular and cellular mechanisms of aging to prevent or reverse age-related diseases.

Key Concepts

  • Cellular Senescence: Aging cells stop dividing and secrete inflammatory factors. Biotech approaches target these senescent cells using “senolytic” drugs to remove them, reducing tissue inflammation and dysfunction.
  • Telomere Maintenance: Telomeres cap the ends of chromosomes, protecting DNA during cell division. With each division, telomeres shorten, leading to cell aging. Biotechnologies aim to activate telomerase or introduce synthetic caps to preserve telomere length.
  • Gene Editing: CRISPR/Cas systems allow precise modifications of aging-related genes. By correcting or silencing genes linked to age-related decline, researchers hope to enhance cellular repair mechanisms and promote healthy lifespan.
  • Regenerative Medicine: Stem cell therapies and tissue engineering aim to replace or repair damaged tissues. Biotech techniques cultivate patient-derived cells in vitro to generate healthy tissues, offering potential treatments for heart disease, neurodegeneration and organ failure.
  • Biomarkers of Aging: Molecular signatures—such as DNA methylation patterns and protein profiles—help measure biological age. Biotechnology develops assays to track these biomarkers, enabling early detection of aging processes and personalized interventions.

Applications and Impact

  1. Pharmaceutical Development: Biotech companies design drugs targeting hallmarks of aging, such as mitochondrial dysfunction and protein aggregation, to treat Alzheimer’s, Parkinson’s and cardiovascular disease.
  2. Diagnostic Tools: Advanced biosensors and genetic tests identify biomarkers of cellular stress and metabolic decline, allowing for early interventions in age-related conditions.
  3. Personalized Medicine: Combining genetic, epigenetic and proteomic data, biotechnology enables tailored treatment plans that address individual aging profiles, optimizing therapy effectiveness and minimizing side effects.
  4. Public Health Strategies: Insights from biotech research inform lifestyle and dietary guidelines that support healthy aging, such as interventions to modulate the gut microbiome and reduce chronic inflammation.

Biotechnology drives the discovery and development of interventions that target fundamental aging processes, offering the potential to extend healthy lifespan and improve quality of life for aging populations worldwide.